Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leu-kaemia-lymphoma. Lancet Oncol 2014; 15: e517-e526.
Watanabe T. Current status of HTLV-1 infection. Int J Hematol 2011; 94: 430-434.
Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 2012; 3: 388.
Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol 1991; 79: 428-437.
Hermine O. ATL treatment: is it time to change? Blood 2015; 126: 2533-2534.
Bazarbachi A, Suarez F, Fields P, Hermine O. How I treat adult T-cell leukemia/ lymphoma. Blood 2011; 118: 1736-1745.
Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y et al. Treatment and survival among 1594 patients with ATL diagnosed in the 2000s: a report from the ATL-PI project performed in Japan. Blood 2015; 126: 2570-2577.
Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009; 27: 453-459.
Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L et al. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood 2014; 123: 3925-3931.
Rosewick N, Durkin K, Artesi M, Marçais A, Hahaut V, Griebel P et al. Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis. Nat Commun 2017; 8: 15264.
Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J-I et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet 2015; 47: 1304-1315.
Percher F, Curis C, Pérès E, Artesi M, Rosewick N, Jeannin P et al. HTLV-1-induced leukotriene B4 secretion by T cells promotes T cell recruitment and virus propagation. Nat Commun 2017; 8: 15890.
Gillet N, Malani N, Melamed A, Gormley N, Carter R, Bentley D et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 2011; 117: 3113-3122.
Firouzi S, López Y, Suzuki Y, Nakai K, Sugano S, Yamochi T et al. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med 2014; 6: 46.
Aoki S, Firouzi S, López Y, Yamochi T, Nakano K, Uchimaru K et al. Transition of adult T-cell leukemia/lymphoma clones during clinical progression. Int J Hematol 2016; 104: 330-337.
